| 000 | 01236 a2200373 4500 | ||
|---|---|---|---|
| 005 | 20250513061209.0 | ||
| 264 | 0 | _c19930521 | |
| 008 | 199305s 0 0 eng d | ||
| 022 | _a1060-0280 | ||
| 024 | 7 |
_a10.1177/106002809302700416 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aShelton, M J | |
| 245 | 0 | 0 |
_aZalcitabine. _h[electronic resource] |
| 260 |
_bThe Annals of pharmacotherapy _cApr 1993 |
||
| 300 |
_a480-9 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aCD4-Positive T-Lymphocytes _xdrug effects |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aChild, Preschool |
| 650 | 0 | 4 | _aClinical Trials, Phase I as Topic |
| 650 | 0 | 4 | _aClinical Trials, Phase II as Topic |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 |
_aHIV Infections _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInfant |
| 650 | 0 | 4 |
_aZalcitabine _xchemistry |
| 650 | 0 | 4 |
_aZidovudine _xtherapeutic use |
| 700 | 1 | _aO'Donnell, A M | |
| 700 | 1 | _aMorse, G D | |
| 773 | 0 |
_tThe Annals of pharmacotherapy _gvol. 27 _gno. 4 _gp. 480-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1177/106002809302700416 _zAvailable from publisher's website |
| 999 |
_c8096741 _d8096741 |
||